Therapeutic Drug Monitoring 2011-10-01

Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.

Marta Concheiro, Hendreé E Jones, Rolley E Johnson, Robin Choo, Marilyn A Huestis

Index: Ther. Drug Monit. 33(5) , 619-26, (2011)

Full Text: HTML

Abstract

Buprenorphine is currently under investigation as a pharmacotherapy to treat pregnant women for opioid dependence. This research evaluates buprenorphine (BUP), norbuprenophine (NBUP), buprenorphine-glucuronide (BUP-Gluc), and norbuprenorphine-glucuronide (NBUP-Gluc) pharmacokinetics after high-dose (14-20 mg) BUP sublingual tablet administration in three opioid-dependent pregnant women.Oral fluid and sweat specimens were collected in addition to plasma specimens for 24 hours during gestation weeks 28 or 29 and 34, and 2 months after delivery. Time to maximum concentration was not affected by pregnancy; however, BUP and NBUP maximum concentration and area under the curve at 0 to 24 hours tended to be lower during pregnancy compared with postpartum levels.Statistically significant but weak positive correlations were found for BUP plasma and OF concentrations and BUP/NBUP ratios in plasma and oral fluid. Statistically significant negative correlations were observed for times of specimen collection and BUP and NBUP oral fluid/plasma ratios. BUP-Gluc and NBUP-Gluc were detected in only 5% of oral fluid specimens. In sweat, BUP and NBUP were detected in only four of 25 (12 or 24 hours) specimens in low concentrations (less than 2.4 ng/patch).These preliminary data describe BUP and metabolite pharmacokinetics in pregnant women and suggest that, like methadone, upward dose adjustments may be needed with advancing gestation.


Related Compounds

Related Articles:

P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

2012-10-01

[J. Pharmacol. Exp. Ther. 343(1) , 53-61, (2012)]

Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.

2011-04-20

[Bioconjug. Chem. 22(4) , 752-8, (2011)]

Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.

2010-01-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(1) , 13-20, (2010)]

An in vitro approach to estimate putative inhibition of buprenorphine and norbuprenorphine glucuronidation.

2010-05-01

[Int. J. Legal Med. 124(3) , 187-94, (2010)]

Development and validation of a method for the determination of buprenorphine and norbuprenorphine in breast milk by gas chromatography-mass spectrometry.

2012-03-01

[Biomed. Chromatogr. 26(3) , 358-62, (2012)]

More Articles...